HPV testing and cervical cancer prevention

Cervical cancer is one of the most prevalent cancers affecting women
worldwide
. Importantly, it is the only type of cancer that can be effectively
prevented, and it is the target of a WHO initiative aimed at eliminating it as
a public health concern by 2030. These unique characteristics place it at the
forefront of microbiology discussions, making it the ideal candidate for the
inaugural CoScience Chapter.

Subscribe to CoScience HUB!

Fill out the form to gain unrestricted access
to this Chapter’s content.

Show privacy policy

Master lecture
“Choice and equity: at the
forefront of cervical cancer
prevention”

In this enlightening speech, Prof. Yin Ling Woo discusses the
global burden of cervical cancer
, emphasizing its
disproportionate impact on women in low- and middle-income
countries while exploring solutions to overcome barriers and
achieve elimination by 2030
.

Educational video
“Transforming Cervical Cancer
Prevention: scientific rationale and
real-world evidence of self-sampling
effectiveness”

Stefania di Costanzo, Copan’s medical affairs manager, provides an
overview of HPV screening accessibility and global efforts to standardize
protocols, improve equity, and incorporate self-sampling into national
testing programs.

White paper
“Agreement between clinician-
and self-collected samples for HPV
detection: an update from the
scientific literature”

The white paper by Stefania di Costanzo offers an insightful, updated
perspective on the latest studies comparing self-collection-driven to
clinician-based HPV screening. It’s a must-read for any professional
looking for an overview of the two methods’ performance and
acceptability.

Join CoScience HUB and get ready
for the following focus

HPV testing and cervical cancer prevention is the first Chapter to be released on CoScience HUB. Create your account now to gain unrestricted access to this invaluable content and stay informed about the upcoming Chapters!